Virtual Medicinal Product (VMP) - Co-beneldopa 25mg/100mg/5ml oral suspension
Name Details
| Name | Start Date | End Date | |
|---|---|---|---|
| Name | Current Name Co-beneldopa 25mg/100mg/5ml oral suspension | Start Date 15-08-2007 | End Date |
Unit Dose & Form Information
- DF Indicator
- Continuous
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Oral
- Form
- Oral suspension
- Ontology Form/Route
- suspension.oral
- Name Basis
- BAN - British Approved Name
Codes
- ATC Code
- N04BA02
- BNF Codes
-
- BNF code 04090100
| Code | Start Date | End Date |
|---|---|---|
| 11815011000001105 | 15-08-2007 |
VMP Ingredients
| Name | Basis of Strength Description | BOSS | Strength and UOM (Nmr) | Strength and UOM (Dmr) |
|---|---|---|---|---|
| Benserazide hydrochloride | Based on Base Substance | Benserazide | 5 mg | 1 ml |
| Levodopa | Based on Ingredient Substance | 20 mg | 1 ml |
Name
Benserazide hydrochloride
Basis of strength description
Based on Base Substance
BOSS
Benserazide
Strength and UOM (Nmr)
5.0
Strength and UOM (Dmr)
1.0
Name
Levodopa
Basis of strength description
Based on Ingredient Substance
BOSS
Strength and UOM (Nmr)
20.0
Strength and UOM (Dmr)
1.0
Parent Products
-
VTMCo-beneldopa
-
VMP(Current) Co-beneldopa 25mg/100mg/5ml oral sus...
-
AMP
-
-
Virtual Medicinal Product Pack (VMPP) Information
| Pack Size | Drug Tariff Price | Drug Tariff Payment Category |
|---|---|---|
| 1 ml |